Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 1;42(45):4635-4637.
doi: 10.1093/eurheartj/ehab658.

The Cornelian dilemma† of quitting DAPT

Zuzana Motovska  1 , Gilles Montalescot  2
Affiliations
Editorial

The Cornelian dilemma† of quitting DAPT

Zuzana Motovska et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Antithrombotic strategies after PCI according to the risk stratification.* ASA, aspirin; ACS, acute coronary syndrome; CAD, coronary artery disease; CLOPI, clopidogrel; DAPT, dual antiplatelet therapy; DAT, dual antithrombotic therapy; PCI, percutaneous coronary intervention; PRASU, prasugrel; RIVAXB, rivaroxaban; SAP, single antiplatelet therapy; TICA, ticagrelor. *The authors’ suggestion.
See this image and copyright information in PMC

Comment on

References

    1. Cleland JG. Is aspirin useful in primary prevention? Eur Heart J 2013;34:3412–3418. - PubMed
    1. Raber I, McCarthy CP, Vaduganathan M, et al. The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet 2019;393:2155–2167. - PubMed
    1. Committee CAPRIE Steering. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329–1339. - PubMed
    1. Koo BK, Kang J, Park KW, et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial. Lancet 2021;397:2487–2496. - PubMed
    1. Warner TD, Nylander S, Whatling C.. Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol 2011;72:619–633. - PMC - PubMed

Substances